The radiopharmaceuticals market is projected to reach US$ 13,818.17 million by 2028 from US$ 7,550.74 million in 2021; it is expected to grow at a CAGR of 9.0% from 2021 to 2028.
The growth of the market is primarily attributed to the rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques. Moreover, the use of nuclear medicines for personalized treatment is expected to foster the market growth during the forecast period. However, the short shelf-life of radiopharmaceuticals and the availability of substitutes hinder the market growth. The medical practices worldwide continue to adapt to the challenges of COVID-19. On the one hand, healthcare professionals are responding to the pandemic, and on the other, it ensures minimal disruption to non-COVID-related procedures and hospitalizations. Hospitals and other healthcare facilities across the world are forced to postpone elective procedures, such as surgeries. Most nonurgent therapies have been postponed.
The global radiopharmaceuticals market is segmented on the basis of type, product type, application, and end user. Based on type, the market is bifurcated into diagnostic nuclear medicine and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is holding a larger share of the market and is anticipated to register a higher CAGR during 2021-2028. By product type, the market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and other. The Technetium-99m segment held the largest share of the market in 2021, whereas the gallium-67 segment is anticipated to register the highest CAGR during the forecast period. By application, the market is segmented into oncology, cardiology, neurology, and others. The oncology segment is holding the largest market. However, the cardiology segment is estimated to register the highest CAGR during the forecast period. By end user, the market is segmented into hospitals, imaging centers, academic and research centers, and others. The hospitals segment is holding the largest market share. However, the imaging centers segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), American Society of Nuclear Cardiology, and American College of Radiology are a few primary and secondary sources referred to while preparing the report on the radiopharmaceuticals market.
The growth of the market is primarily attributed to the rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques. Moreover, the use of nuclear medicines for personalized treatment is expected to foster the market growth during the forecast period. However, the short shelf-life of radiopharmaceuticals and the availability of substitutes hinder the market growth. The medical practices worldwide continue to adapt to the challenges of COVID-19. On the one hand, healthcare professionals are responding to the pandemic, and on the other, it ensures minimal disruption to non-COVID-related procedures and hospitalizations. Hospitals and other healthcare facilities across the world are forced to postpone elective procedures, such as surgeries. Most nonurgent therapies have been postponed.
The global radiopharmaceuticals market is segmented on the basis of type, product type, application, and end user. Based on type, the market is bifurcated into diagnostic nuclear medicine and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is holding a larger share of the market and is anticipated to register a higher CAGR during 2021-2028. By product type, the market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and other. The Technetium-99m segment held the largest share of the market in 2021, whereas the gallium-67 segment is anticipated to register the highest CAGR during the forecast period. By application, the market is segmented into oncology, cardiology, neurology, and others. The oncology segment is holding the largest market. However, the cardiology segment is estimated to register the highest CAGR during the forecast period. By end user, the market is segmented into hospitals, imaging centers, academic and research centers, and others. The hospitals segment is holding the largest market share. However, the imaging centers segment is estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), American Society of Nuclear Cardiology, and American College of Radiology are a few primary and secondary sources referred to while preparing the report on the radiopharmaceuticals market.
Reasons to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the radiopharmaceuticals market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Radiopharmaceuticals Market - By Type
1.3.2 Global Radiopharmaceuticals Market - By Product Type
1.3.3 Global Radiopharmaceuticals Market - By Application
1.3.4 Global Radiopharmaceuticals Market - By End User
1.3.5 Global Radiopharmaceuticals Market- By Geography
2. Global Radiopharmaceuticals Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Radiopharmaceuticals Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. Radiopharmaceuticals Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Suitability of Alpha Radioimmunotherapy in Targeted Cancer Treatment
5.1.3 Advancements in Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Short Shelf-Life of Radiopharmaceuticals
5.2.2 Availability of Substitutes
5.3 Market Opportunities
5.3.1 High Growth Potential in Developing Countries
5.4 Future Trends
5.4.1 Use of Nuclear Medicine for Personalized Treatment
5.5 Impact Analysis
6. Radiopharmaceuticals Market- Global Analysis
6.1 Global Radiopharmaceuticals Market Revenue Forecast and Analysis
6.2 Global Radiopharmaceuticals Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Radiopharmaceuticals Market Analysis - By Type
7.1 Overview
7.2 Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Nuclear Medicine
7.3.1 Overview
7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 (Single-Photon Emission Computed Tomography) Applications
7.3.3.1 Overview
7.3.3.2 SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 PET (Positron Emission Tomography) Applications
7.3.4.1 Overview
7.3.4.2 PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Therapeutic Nuclear Medicine
7.4.1 Overview
7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Alpha Emitters
7.4.3.1 Overview
7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Beta Emitters
7.4.4.1 Overview
7.4.4.2 Beta Emitters: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Brachytherapy Isotopes
7.4.5.1 Overview
7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8. Radiopharmaceuticals Market Analysis - By Product Type
8.1 Overview
8.2 Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)
8.3 Iodine-131
8.3.1 Overview
8.3.2 Iodine-131: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Gallium-67
8.4.1 Overview
8.4.2 Gallium-67: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Thallium-201
8.5.1 Overview
8.5.2 Thallium-201: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Technetium-99m
8.6.1 Overview
8.6.2 Technetium-99m: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Copper-64
8.7.1 Overview
8.7.2 Copper-64: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Other
8.8.1 Overview
8.8.2 Other: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9. Radiopharmaceuticals Market Analysis - By Application
9.1 Overview
9.2 Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
9.3 Oncology
9.3.1 Overview
9.3.2 Oncology: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiology
9.4.1 Overview
9.4.2 Cardiology: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Neurology
9.5.1 Overview
9.5.2 Neurology: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
10. Radiopharmaceuticals Market Analysis - By End User
10.1 Overview
10.2 Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Imaging Centres
10.4.1 Overview
10.4.2 Imaging Centres: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Centers
10.5.1 Overview
10.5.2 Academic and Research Centers: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
11. Global Radiopharmaceuticals Market - Geographic Analysis
11.1 North America: Radiopharmaceuticals Market
11.1.1 Overview
11.1.2 North America: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Radiopharmaceuticals Market, by Type, 2019-2028 (USD Million)
11.1.3.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.1.3.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.1.4 North America: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.1.5 North America: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.1.6 North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.1.6.1 US: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.1 US: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.1.2 US: Radiopharmaceuticals Market, by Type, 2019-2028 (USD Million)
11.1.6.1.2.1 US: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.1.2.2 US: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.1.3 US: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.1.6.1.4 US: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.1.6.2 Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.2.1 Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.2.2 Canada: Radiopharmaceuticals Market, by Type, 2019-2028 (USD Million)
11.1.6.2.2.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.2.2.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.2.3 Canada: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.1.6.2.4 Canada: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.1.6.3 Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.3.1 Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.1.6.3.2 Mexico: Radiopharmaceuticals Market, by Type - 2019-2028 (USD Million)
11.1.6.3.2.1 Mexico: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.3.2.2 Mexico: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.1.6.3.3 Mexico: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.1.6.3.4 Mexico: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2 Europe: Radiopharmaceuticals Market
11.2.1 Overview
11.2.2 Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.3.1 Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.3.2 Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.4 Europe: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.5 Europe: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6 Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.2.6.1 Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.1.1 Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.1.2 Germany: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.1.2.1 Germany: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.1.2.2 Germany: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.1.3 Germany: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.1.4 Germany: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6.2 France: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.2.1 France: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.2.2 France: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.2.2.1 France: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.2.2.2 France: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.2.3 France: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.2.4 France: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6.3 UK: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.3.1 UK: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.3.2 UK: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.3.2.1 UK: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.3.2.2 UK: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.3.3 UK: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.3.4 UK: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6.4 Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.4.1 Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.4.2 Italy: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.4.2.1 Italy: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.4.2.2 Italy: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.4.3 Italy: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.4.4 Italy: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6.5 Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.5.1 Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.5.2 Spain: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.5.2.1 Spain: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.5.2.2 Spain: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.5.3 Spain: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.5.4 Spain: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.2.6.6 Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.6.1 Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.2.6.6.2 Rest of Europe: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.2.6.6.2.1 Rest of Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.6.2.2 Rest of Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.2.6.6.3 Rest of Europe: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.2.6.6.4 Rest of Europe: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3 Asia Pacific: Radiopharmaceuticals Market
11.3.1 Overview
11.3.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.3.1 Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.3.2 Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.5 Asia Pacific: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.3.6.1 China: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.1.1 China: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.1.2 China: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.1.3 China: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.1.4 China: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6.2 Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.2.1 Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6.3 India: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.3.1 India: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.3.2 India: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.3.3 India: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.3.4 India: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6.4 Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.4.1 Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6.5 South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.5.1 South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.3.6.6 Rest of Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.6.1 Rest of Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)
11.3.6.6.2 Rest of Asia Pacific: Radiopharmaceuticals Market, By Type, 2019-2028 (USD Million)
11.3.6.6.2.1 Rest of Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.6.2.2 Rest of Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.3.6.6.3 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2019-2028 (USD Million)
11.3.6.6.4 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2019-2028 (USD Million)
11.4 Middle East and Africa: Radiopharmaceuticals Market
11.4.1 Overview
11.4.2 Middle East & Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East and Africa Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.3.1 Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.4.3.2 Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.4.4 Middle East and Africa Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.4.5 Middle East and Africa Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6 Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.4.6.1 Saudi Arabia: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.1.1 Saudi Arabia: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.4.6.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6.2 UAE: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.2.1 UAE: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.2.2 UAE Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.2.3 UAE Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.4 UAE Radiopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.4.6.3 South Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.3.1 South Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.3.2 South Africa Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.3.3 South Africa Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.4.6.3.4 South Africa Radiopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.4.6.4 Rest of Middle East and Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.4.1 Rest of Middle East and Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)
11.4.6.4.2 Rest of Middle East and Africa Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.2.1 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.4.2.2 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.4.6.4.3 Rest of Middle East and Africa Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.4 Rest of Middle East and Africa Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.5 South and Central America: Radiopharmaceuticals Market
11.5.1 Overview
11.5.2 South and Central America: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Radiopharmaceuticals Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.5.3.1 South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.5.3.2 South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.5.4 South and Central America Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
11.5.6.1 Brazil: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.1.1 Brazil: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.1.2 Brazil Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.5.6.1.2.1 Brazil: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.1.2.2 Brazil: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.1.3 Brazil Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.5.6.1.4 Brazil Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.5.6.2 Argentina: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.2.1 Argentina: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.2.2 Argentina Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.5.6.2.2.1 Argentina: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.2.2.2 Argentina: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.2.3 Argentina Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.5.6.2.4 Argentina Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.5.6.3 Rest of South and Central America: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.3.1 Rest of South and Central America: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (USD Million)
11.5.6.3.2 Rest of South and Central America Radiopharmaceuticals Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.5.6.3.2.1 Rest of South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.3.2.2 Rest of South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019-2028 (USD Million)
11.5.6.3.3 Rest of South and Central America Radiopharmaceuticals Market, by Application- Revenue and Forecast to 2028 (USD Million)
11.5.6.3.4 Rest of South and Central America Radiopharmaceuticals Market, by End User- Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Radiopharmaceuticals Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Radiopharmaceuticals Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Cardinal Health Inc
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Curium
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GENERAL ELECTRIC
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lantheus Medical Imaging, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bracco Imaging S.p.A
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ECZACIBAŞI MONROL NUCLEAR PRODUCTS CO.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Nordion
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 NTP RADIOISOTOPES
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Advanced Accelerator Applications
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Publisher
15.2 Glossary of TermsList of Tables
Table 1. Principal Radionuclides Used in Diagnostic Radiopharmaceuticals
Table 2. North America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. US Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 9. US Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 10. US Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. US Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 14. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Canada Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 26. Europe Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 27. Germany: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Germany Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 30. Germany: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Germany: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 32. France: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 33. France Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 34. France Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 35. France: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 36. France: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 37. UK: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 38. UK Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 39. UK Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 40. UK: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 41. UK: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 42. Italy: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 43. Italy Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 44. Italy Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 45. Italy: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 46. Italy: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 47. Spain: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 48. Spain Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 49. Spain Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 50. Spain: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 51. Spain: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Rest of Europe: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 61. Asia Pacific Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 62. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 63. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 64. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 65. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 66. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 71. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 72. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 73. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 74. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 75. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 77. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 78. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 79. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 80. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 82. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 83. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 84. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 85. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 86. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 96. Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 101. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 106. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 111. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 121. South and Central America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 126. Brazil Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 131. Argentina Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 136. Rest of South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 137. Recent Inorganic Growth Strategies in the Radiopharmaceuticals Market
Table 138. Recent Organic Growth Strategies in the Radiopharmaceuticals Market
Table 139. Glossary of Terms, Radiopharmaceuticals MarketList of Figures
Figure 1. Radiopharmaceuticals Market Segmentation
Figure 2. Radiopharmaceuticals Market Segmentation, By Region
Figure 3. Global Radiopharmaceuticals Market Overview
Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Type Segment in Radiopharmaceuticals Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Radiopharmaceuticals Market, by Geography (US$ Million)
Figure 7. Global Radiopharmaceuticals Market– Leading Country Markets (US$ Million)
Figure 8. Global Radiopharmaceuticals Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
Figure 15. Global Radiopharmaceuticals Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Radiopharmaceuticals Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Radiopharmaceuticals Market
Figure 18. Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
Figure 19. Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)
Figure 27. Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Gallium-67: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Thallium-201: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Copper-64: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Other: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
Figure 34. Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)
Figure 39. Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. North America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. North America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 45. North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 46. US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Europe: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 50. Europe Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 52. Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Asia Pacific: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 59. Asia Pacific Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 61. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Middle East and Africa: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 68. Middle East & Africa Radiopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 70. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 71. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 72. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 74. South and Central America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 75. South and Central America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 77. Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 78. Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 80. Impact of COVID-19 Pandemic in North American Country Markets
Figure 81. Impact of COVID-19 Pandemic in European Country Markets
Figure 82. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 83. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 84. Impact of COVID-19 Pandemic in South & Central America Market
Figure 85. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardinal Health
- GE Healthcare
- Curium
- Lantheus Medical Imaging
- Bayer AG
- Bracco Imaging
- Eczacýbaþý-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- NTP Radioisotopes
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | August 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 7550.74 Million |
| Forecasted Market Value ( USD | $ 13818.17 Million |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
